Hello, has anybody more information about the therapy with nilotinib, one study with eleven Patients showed very good results (improvent in 10 patients). Open Study not doubleblind). If the results are correct, the "holy grail" of parkinson therapy.
To me it seems likt a therapy with antibiotics, you need no double blind studies to find a proof for the effect. (If you have 10 Patients with bacterial pneumonia without therapy 8 or 9 will die, with antibiotica none or one).
How long will it take until this medical drug, which is already approrved for the therapy of CML will be available for parkinsons patients?